Jane Street
ABEO icon

Jane Street’s Abeona Therapeutics ABEO Stock Holding History

Jane Street’s Portfolio ABEO Stock Details ABEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-68,614
Closed -$435K – 10656
2025
Q2 		$390K Sell
68,614
-60,305
-47% -$343K ﹤0.01% 7390
2025
Q1 		$614K Sell
128,919
-2,559
-2% -$13.9K ﹤0.01% 6485
2024
Q4 		$732K Buy
131,478
+118,262
+895% +$728K ﹤0.01% 5970
2024
Q3 		$83.5K Buy
+13,216
New +$69K ﹤0.01% 9049
2024
Q2 		– Sell
-64,511
Closed -$468K – 9235
2024
Q1 		$468K Buy
64,511
+23,624
+58% +$150K ﹤0.01% 6797
2023
Q4 		$205K Buy
+40,887
New +$180K ﹤0.01% 8188
2023
Q1 		– Sell
-37,401
Closed -$115K – 8905
2022
Q4 		$115K Buy
+37,401
New +$140K ﹤0.01% 8020
2022
Q3 		– Sell
-1,297
Closed -$7K – 9599
2022
Q2 		$7K Buy
1,297
+109
+9% +$551 ﹤0.01% 9364
2022
Q1 		$9K Buy
+1,188
New +$8.16K ﹤0.01% 10081
2021
Q4 		– Sell
-588
Closed -$16K – 9963
2021
Q3 		$16K Sell
588
-2,202
-79% -$70.5K ﹤0.01% 9770
2021
Q2 		$109K Buy
2,790
+279
+11% +$11.4K ﹤0.01% 9217
2021
Q1 		$118K Buy
+2,511
New +$138K ﹤0.01% 8571
2020
Q4 		– Sell
-610
Closed -$16K – 7396
2020
Q3 		$16K Buy
+610
New +$38.5K ﹤0.01% 7040
2020
Q2 		– Sell
-578
Closed -$30K – 7007
2020
Q1 		$30K Buy
+578
New +$38.6K ﹤0.01% 5148
2019
Q1 		– Sell
-535
Closed -$96K – 4925
2018
Q4 		$96K Sell
535
-1,006
-65% -$219K ﹤0.01% 4633
2018
Q3 		$493K Buy
+1,541
New +$547K ﹤0.01% 3633

Other funds holding ABEO

NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
CCC
Cable Car Capital San Francisco, California $289M AUM 26.33% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
PBM
Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Jane Street's ABEO Position: Q3 2025 in Review

Jane Street sold out of Abeona Therapeutics (ABEO) in Q3 2025, closing a stake of 68,614 shares — an estimated $435K sold.

Jane Street first reported a position in ABEO in Q3 2018 and held it in 16 quarters. The position peaked at $732K in Q4 2024. 100 funds tracked by Wall St. Rank hold ABEO as of Q3 2025.

  • Jane Street reported no remaining Abeona Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Jane Street sold 68,614 Abeona Therapeutics shares in Q3 2025, an estimated $435K.
  • Jane Street first reported a position in Abeona Therapeutics in Q3 2018 and held it in 16 quarters.
  • Jane Street's Abeona Therapeutics position peaked at $732K in Q4 2024.
  • 100 funds tracked by Wall St. Rank held Abeona Therapeutics as of Q3 2025.

Based on Jane Street's 13F filing for Q3 2025, filed 14 Nov 2025.